ZEPTIDE INJECTION - 2.5MG - 5MG

Zeptide injection is a brand of Tirzepatide, a prescription medication used to manage type 2 diabetes and chronic weight issues by stimulating insulin secretion and decreasing appetite.

It is administered as a weekly, subcutaneous injection, with common starting doses of 2.5 mg and a maximum of 15 mg.

Key Information on Zeptide Injection

Indications: Primarily used for managing Type 2 diabetes mellitus, weight reduction, and management in adults with obesity or weight-related conditions.

Active Ingredient: Tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist.

Dosage Information:

Initial: 2.5 mg once weekly for four weeks.

Maintenance: Increased to 5 mg once weekly, with further escalations possible up to a maximum of 15 mg weekly.

Administration: Subcutaneous injection (under the skin) into the stomach, thigh, or upper arm. It should be refrigerated (2°C-8°C) and not frozen.

Side Effects: The most common side effects are gastrointestinal, including nausea, diarrhea, vomiting, and constipation.

Contraindications: Should not be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or those with type 1 diabetes.